Corin Group announced the first successfully completed cases using its Apollo surgical robot and ApolloKnee software for total knee arthroplasty.
Dr. Jeff Lawrence, based in Wisconsin, performed the landmark case. Apollo, along with the ApolloKnee software, picked up FDA clearance in November 2023. The system features BalanceBot technology and builds upon a decade of Corin Group technology. The company designed it to focus on future enhancements in patient outcomes while providing a more intuitive experience for surgeons.
Apollo provides surgeons with the tools to create and precisely implement personalized surgical plans throughout the arthroplasty procedure. Surgeons can learn from past procedures by reviewing data from before and after, along with patient-reported outcomes.
“With Apollo, I can consistently achieve a personalized, dynamic balance of the knee and with fewer soft-tissue releases,” Lawrence said. “Clinically, this results in less pain, better function, and improved outcomes for my patients. I have also been quite impressed by the new ApolloKnee workflow, which features efficient gesture controls and autonomous planning. I’m very excited by the experience from my first cases and look forward to bringing this technology to all my patients in the future.”
Other features include autonomous planning, gesture-controlled workflows and a robotic cutting guide. The system supports multiple surgical applications and streamlines wireless integration to its CorinConnect platform.
“This is a proud moment for Corin, the realization of our vision to bring personalized dynamic balance to patients around the world. We look forward to sharing additional information in the coming weeks as the first Apollo patients reach new milestones in their joint replacement journey,” Jon Serbousek, CEO of Corin Group and senior advisor to parent company Permira, said.
